Medizen Humancare Co (XKRX:236340) FCF Margin % : -22.80% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Medizen Humancare Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medizen Humancare Co's Free Cash Flow for the six months ended in Dec. 2023 was ₩-1,043 Mil. Medizen Humancare Co's Revenue for the six months ended in Dec. 2023 was ₩4,575 Mil. Therefore, Medizen Humancare Co's FCF Margin % for the quarter that ended in Dec. 2023 was -22.80%.

As of today, Medizen Humancare Co's current FCF Yield % is -11.73%.

The historical rank and industry rank for Medizen Humancare Co's FCF Margin % or its related term are showing as below:

XKRX:236340' s FCF Margin % Range Over the Past 10 Years
Min: -136.51 Med: -73.79 Max: -22.8
Current: -22.8

During the past 7 years, the highest FCF Margin % of Medizen Humancare Co was -22.80%. The lowest was -136.51%. And the median was -73.79%.

XKRX:236340's FCF Margin % is ranked worse than
62.62% of 214 companies
in the Medical Diagnostics & Research industry
Industry Median: -7.435 vs XKRX:236340: -22.80

Medizen Humancare Co FCF Margin % Historical Data

The historical data trend for Medizen Humancare Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medizen Humancare Co FCF Margin % Chart

Medizen Humancare Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-89.35

-136.51

-47.64

-80.39

-22.80

Medizen Humancare Co Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
FCF Margin %	Get a 7-Day Free Trial			-89.35	-136.51	-47.64	-80.39	-22.80

Competitive Comparison of Medizen Humancare Co's FCF Margin %

For the Diagnostics & Research subindustry, Medizen Humancare Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medizen Humancare Co's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medizen Humancare Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Medizen Humancare Co's FCF Margin % falls into.

Medizen Humancare Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Medizen Humancare Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1043.078	/	4575.018
	=	-22.80 %

Medizen Humancare Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1043.078	/	4575.018
	=	-22.80 %

Medizen Humancare Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Medizen Humancare Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medizen Humancare Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medizen Humancare Inc Co Ltd (XKRX:236340) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Republic of Korea 223, Teheran-ro, Gangnam-gu, Seoul, KOR

Website

http://www.medizencare.com

Medizen Humancare Inc Co Ltd is a R&D company providing genomics involving acquisition of disease specific genome contents, identification of new drug candidate genes and development of new preventive measures.

Medizen Humancare Co Headlines

No Headlines